The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of O'kane Kieran since 2022.
This trader's CIK number is 1828131.
At the time of last reporting, O'kane Kieran was the Chief Commercial Officer of Biodesix Inc. (stock ticker symbol BDSX).
Also see all insider trading activities at Biodesix Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | BDSX | 0 | $0 | 18,480 | $16,561 | 51,097 | $0 |
| 2024 | BDSX | 0 | $0 | 12,664 | $22,555 | 48,082 | $0 |
| 2023 | BDSX | 0 | $0 | 5,864 | $9,097 | 17,873 | $0 |
| 2022 | BDSX | 0 | $0 | 4,961 | $8,882 | 16,384 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-12 | BDSX | Option Ex | 1,489 | .00 | 0 |
| 2025-08-13 | BDSX | Sale | 476 | .42 | 198 |
| 2025-05-09 | BDSX | Option Ex | 1,490 | .00 | 0 |
| 2025-05-12 | BDSX | Sale | 239 | .36 | 85 |
| 2025-05-13 | BDSX | Sale | 238 | .35 | 84 |
| 2025-02-10 | BDSX | Option Ex | 48,118 | .00 | 0 |
| 2025-02-11 | BDSX | Sale | 17,527 | .92 | 16,194 |
| 2024-08-12 | BDSX | Sale | 120 | 1.57 | 188 |
| 2024-08-09 | BDSX | Sale | 345 | 1.60 | 552 |
| 2024-08-08 | BDSX | Option Ex | 1,489 | .00 | 0 |
| 2024-05-23 | BDSX | Option Ex | 13,080 | .00 | 0 |
| 2024-05-08 | BDSX | Option Ex | 1,489 | .00 | 0 |
| 2024-05-09 | BDSX | Sale | 468 | 1.48 | 692 |
| 2024-02-12 | BDSX | Sale | 5,412 | 1.67 | 9,010 |
| 2024-02-08 | BDSX | Option Ex | 32,024 | .00 | 0 |
| 2024-02-09 | BDSX | Sale | 6,319 | 1.92 | 12,113 |
| 2023-11-08 | BDSX | Option Ex | 1,489 | .00 | 0 |
| 2023-11-09 | BDSX | Sale | 234 | 1.27 | 297 |
| 2023-11-10 | BDSX | Sale | 235 | 1.23 | 288 |
| 2023-08-08 | BDSX | Option Ex | 5,462 | .00 | 0 |
| 2023-08-09 | BDSX | Sale | 850 | 1.39 | 1,179 |
| 2023-08-10 | BDSX | Sale | 849 | 1.27 | 1,075 |
| 2023-05-09 | BDSX | Sale | 1,223 | 1.57 | 1,915 |
| 2023-05-10 | BDSX | Sale | 474 | 1.58 | 747 |
| 2023-05-08 | BDSX | Option Ex | 5,461 | .00 | 0 |
| 2023-02-08 | BDSX | Option Ex | 5,461 | .00 | 0 |
| 2023-02-09 | BDSX | Sale | 1,999 | 1.80 | 3,596 |
| 2022-11-08 | BDSX | Option Ex | 5,461 | .00 | 0 |
| 2022-11-09 | BDSX | Sale | 952 | 1.04 | 991 |
| 2022-11-10 | BDSX | Sale | 753 | 1.02 | 766 |
| 2022-08-09 | BDSX | Sale | 1,673 | 2.53 | 4,229 |
| 2022-08-08 | BDSX | Option Ex | 5,462 | .00 | 0 |
| 2022-05-09 | BDSX | Option Ex | 5,461 | .00 | 0 |
| 2022-05-10 | BDSX | Sale | 1,583 | 1.83 | 2,896 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by O'kane Kieran (Chief Commercial Officer of Biodesix Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.